Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status
Asensio Lopez, Maria del Carmen, Lax, Antonio, Hernandez Vicente, Alvaro, Saura Guillen, Elena, Hernandez-Martinez, Antonio, Fernandez del Palacio, Maria Josefa, Bayes-Genis, Antoni, Pascual Figal, Domingo A.
Published in Scientific reports (11.08.2020)
Published in Scientific reports (11.08.2020)
Get full text
Journal Article
Pharmacological inhibition of the mitochondrial NADPH oxidase 4/PKCα/Gal-3 pathway reduces left ventricular fibrosis following myocardial infarction
Asensio-Lopez, Maria del Carmen, Lax, Antonio, Fernandez del Palacio, Maria Josefa, Sassi, Yassine, Hajjar, Roger J., Pascual-Figal, Domingo A.
Published in Translational research : the journal of laboratory and clinical medicine (01.09.2018)
Published in Translational research : the journal of laboratory and clinical medicine (01.09.2018)
Get full text
Journal Article
Silencing of microRNA-106b-5p prevents doxorubicin-mediated cardiotoxicity through modulation of the PR55α/YY1/sST2 signaling axis
Lax, Antonio, Soler, Fernando, Fernandez del Palacio, Maria Josefa, Pascual-Oliver, Silvia, Ballester, Miriam Ruiz, Fuster, Jose Javier, Pascual-Figal, Domingo, Asensio-Lopez, Maria del Carmen
Published in Molecular therapy. Nucleic acids (13.06.2023)
Published in Molecular therapy. Nucleic acids (13.06.2023)
Get full text
Journal Article
Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status
del Carmen Asensio Lopez, Maria, Lax, Antonio, Hernandez Vicente, Alvaro, Saura Guillen, Elena, Hernandez-Martinez, Antonio, Fernandez del Palacio, Maria Josefa, Bayes-Genis, Antoni, Pascual Figal, Domingo A.
Published in Scientific reports (09.10.2020)
Published in Scientific reports (09.10.2020)
Get full text
Journal Article
Modulation of IL-33/ST2 system in postinfarction heart failure: correlation with cardiac remodelling markers
Sánchez-Más, Jesús, Lax, Antonio, Asensio-López, María del Carmen, Fernandez-Del Palacio, Maria J., Caballero, Luis, Santarelli, Giorgia, Januzzi, James L., Pascual-Figal, Domingo A.
Published in European journal of clinical investigation (01.07.2014)
Published in European journal of clinical investigation (01.07.2014)
Get full text
Journal Article
Modulation of IL ‐33/ ST 2 system in postinfarction heart failure: correlation with cardiac remodelling markers
Sánchez‐Más, Jesús, Lax, Antonio, Asensio‐López, María del Carmen, Fernandez‐Del Palacio, Maria J., Caballero, Luis, Santarelli, Giorgia, Januzzi, James L., Pascual‐Figal, Domingo A.
Published in European journal of clinical investigation (01.07.2014)
Published in European journal of clinical investigation (01.07.2014)
Get full text
Journal Article
ANTAGONIST OF THE MIRNA-106B-5P TO TREAT OR PREVENT THE CARDIOTOXICITY THAT IS DEVELOPED IN ONCOLOGIC PATIENTS AFTER RECEIVING ANTHRACYCLINE-BASED CHEMOTHERAPY
PASCUAL FIGAL, Domingo Andrés, ASENSIO LÓPEZ, María del Carmen, LAX PÉREZ, Antonio Manuel
Year of Publication 04.09.2024
Get full text
Year of Publication 04.09.2024
Patent
ANTAGONIST OF THE MIRNA-106B-5P TO TREAT OR PREVENT THE CARDIOTOXICITY THAT IS DEVELOPED IN ONCOLOGIC PATIENTS AFTER RECEIVING ANTHRACYCLINE-BASED CHEMOTHERAPY
PASCUAL FIGAL, Domingo Andrés, ASENSIO LÓPEZ, María del Carmen, LAX PÉREZ, Antonio Manuel
Year of Publication 04.05.2023
Get full text
Year of Publication 04.05.2023
Patent
ANTAGONIST OF THE MIRNA-106B-5P TO TREAT OR PREVENT THE CARDIOTOXICITY THAT IS DEVELOPED IN ONCOLOGIC PATIENTS AFTER RECEIVING ANTHRACYCLINE-BASED CHEMOTHERAPY
PASCUAL FIGAL, Domingo Andrés, ASENSIO LÓPEZ, María del Carmen, LAX PÉREZ, Antonio Manuel
Year of Publication 03.05.2023
Get full text
Year of Publication 03.05.2023
Patent